YAP1 and breast cancer: Testing a library of 96 antineoplastic and cardiotherapeutic drugs routinely used in clinics, we found that doxorubicin was the strongest inducer of YAP/TAZ nuclear translocation in both breast cancer cells and hiPSC‐CMs.